BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 25667327)

  • 21. Recapitulation of the hepatitis C virus life-cycle in engineered murine cell lines.
    Vogt A; Scull MA; Friling T; Horwitz JA; Donovan BM; Dorner M; Gerold G; Labitt RN; Rice CM; Ploss A
    Virology; 2013 Sep; 444(1-2):1-11. PubMed ID: 23777661
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human pluripotent stem cell-derived hepatocytes support complete replication of hepatitis C virus.
    Roelandt P; Obeid S; Paeshuyse J; Vanhove J; Van Lommel A; Nahmias Y; Nevens F; Neyts J; Verfaillie CM
    J Hepatol; 2012 Aug; 57(2):246-51. PubMed ID: 22521345
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Saikosaponin b2 is a naturally occurring terpenoid that efficiently inhibits hepatitis C virus entry.
    Lin LT; Chung CY; Hsu WC; Chang SP; Hung TC; Shields J; Russell RS; Lin CC; Li CF; Yen MH; Tyrrell DL; Lin CC; Richardson CD
    J Hepatol; 2015 Mar; 62(3):541-8. PubMed ID: 25450204
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of human hepatocyte-like cells derived from induced pluripotent stem cells as a model for hepatocytes in hepatitis C virus infection.
    Yoshida T; Takayama K; Kondoh M; Sakurai F; Tani H; Sakamoto N; Matsuura Y; Mizuguchi H; Yagi K
    Biochem Biophys Res Commun; 2011 Dec; 416(1-2):119-24. PubMed ID: 22093821
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Permissiveness of human hepatoma cell lines for HCV infection.
    Sainz B; Barretto N; Yu X; Corcoran P; Uprichard SL
    Virol J; 2012 Jan; 9():30. PubMed ID: 22273112
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CLEC4M-positive and CD81-negative Huh7 cells are not susceptible to JFH-1 HCVcc infection but mediate transinfection.
    Ishibashi M; Morita N; Nomura-Kawaguchi C; Shimizu Y; Wakita T; Esumi M
    Arch Virol; 2014 Nov; 159(11):2949-55. PubMed ID: 24965233
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatitis C virus-host interactions, replication, and viral assembly.
    Shulla A; Randall G
    Curr Opin Virol; 2012 Dec; 2(6):725-32. PubMed ID: 23083892
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glucocorticosteroids increase cell entry by hepatitis C virus.
    Ciesek S; Steinmann E; Iken M; Ott M; Helfritz FA; Wappler I; Manns MP; Wedemeyer H; Pietschmann T
    Gastroenterology; 2010 May; 138(5):1875-84. PubMed ID: 20152835
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Entry of pseudotyped hepatitis C virus into primary human hepatocytes depends on the scavenger class B type I receptor.
    Régeard M; Trotard M; Lepère C; Gripon P; Le Seyec J
    J Viral Hepat; 2008 Dec; 15(12):865-70. PubMed ID: 19087225
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mouse-specific residues of claudin-1 limit hepatitis C virus genotype 2a infection in a human hepatocyte cell line.
    Haid S; Windisch MP; Bartenschlager R; Pietschmann T
    J Virol; 2010 Jan; 84(2):964-75. PubMed ID: 19889758
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatitis C virus triggers apoptosis of a newly developed hepatoma cell line through antiviral defense system.
    Zhu H; Dong H; Eksioglu E; Hemming A; Cao M; Crawford JM; Nelson DR; Liu C
    Gastroenterology; 2007 Nov; 133(5):1649-59. PubMed ID: 17983809
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Claudin-1, miR-122 and apolipoprotein E transductions improve the permissivity of SNU-182, SNU-398 and SNU-449 hepatoma cells to hepatitis C virus.
    Fournier C; Hoffmann TW; Morel V; Descamps V; Dubuisson J; Brochot E; Francois C; Duverlie G; Castelain S; Helle F
    J Viral Hepat; 2018 Jan; 25(1):63-71. PubMed ID: 28772350
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatocytes that express variants of cyclophilin A are resistant to HCV infection and replication.
    von Hahn T; Schiene-Fischer C; Van ND; Pfaender S; Karavul B; Steinmann E; Potthoff A; Strassburg C; Hamdi N; Abdelaziz AI; Sarrazin C; Müller T; Berg T; Trépo E; Wedemeyer H; Manns MP; Pietschmann T; Ciesek S
    Gastroenterology; 2012 Aug; 143(2):439-47.e1. PubMed ID: 22580540
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The tight junction proteins claudin-1, -6, and -9 are entry cofactors for hepatitis C virus.
    Meertens L; Bertaux C; Cukierman L; Cormier E; Lavillette D; Cosset FL; Dragic T
    J Virol; 2008 Apr; 82(7):3555-60. PubMed ID: 18234789
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Single-nucleotide variants in human CD81 influence hepatitis C virus infection of hepatoma cells.
    Alberione MP; Moeller R; Kirui J; Ginkel C; Doepke M; Ströh LJ; Machtens JP; Pietschmann T; Gerold G
    Med Microbiol Immunol; 2020 Aug; 209(4):499-514. PubMed ID: 32322956
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Polyphenols Inhibit Hepatitis C Virus Entry by a New Mechanism of Action.
    Calland N; Sahuc ME; Belouzard S; Pène V; Bonnafous P; Mesalam AA; Deloison G; Descamps V; Sahpaz S; Wychowski C; Lambert O; Brodin P; Duverlie G; Meuleman P; Rosenberg AR; Dubuisson J; Rouillé Y; Séron K
    J Virol; 2015 Oct; 89(19):10053-63. PubMed ID: 26202241
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Up-regulation of the ATP-binding cassette transporter A1 inhibits hepatitis C virus infection.
    Bocchetta S; Maillard P; Yamamoto M; Gondeau C; Douam F; Lebreton S; Lagaye S; Pol S; Helle F; Plengpanich W; Guérin M; Bourgine M; Michel ML; Lavillette D; Roingeard P; le Goff W; Budkowska A
    PLoS One; 2014; 9(3):e92140. PubMed ID: 24646941
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatitis C virus infects rhesus macaque hepatocytes and simianized mice.
    Scull MA; Shi C; de Jong YP; Gerold G; Ries M; von Schaewen M; Donovan BM; Labitt RN; Horwitz JA; Gaska JM; Hrebikova G; Xiao JW; Flatley B; Fung C; Chiriboga L; Walker CM; Evans DT; Rice CM; Ploss A
    Hepatology; 2015 Jul; 62(1):57-67. PubMed ID: 25820364
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Occult infection of peripheral B cells by hepatitis C variants which have low translational efficiency in cultured hepatocytes.
    Durand T; Di Liberto G; Colman H; Cammas A; Boni S; Marcellin P; Cahour A; Vagner S; Féray C
    Gut; 2010 Jul; 59(7):934-42. PubMed ID: 20442199
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reconstitution of the entire hepatitis C virus life cycle in nonhepatic cells.
    Da Costa D; Turek M; Felmlee DJ; Girardi E; Pfeffer S; Long G; Bartenschlager R; Zeisel MB; Baumert TF
    J Virol; 2012 Nov; 86(21):11919-25. PubMed ID: 22896615
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.